Overview

A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of BPN14770 in Male Adults (Aged 18 to 45) with Fragile X Syndrome
Phase:
Phase 3
Details
Lead Sponsor:
Tetra Discovery Partners